BRCA2 and breast carcinoma: TNBC accounts for about 70% and 16–23% of BRCA1 and BRCA2 mutation carriers, respectively (Stevens & Couch, 2013), suggesting that TNBC is also inextricably linked to germline mutation in this breast cancer susceptibility gene.